2023
DOI: 10.1016/j.pharmthera.2023.108502
|View full text |Cite
|
Sign up to set email alerts
|

The Triple Crown: NO, CO, and H2S in cancer cell biology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(3 citation statements)
references
References 530 publications
0
3
0
Order By: Relevance
“…However, gasotransmitters do not act individually in the body; they are usually implemented in physiological processes on either a synergistic or antagonistic role through subtle interactions among them. 48 By availing of the reversibility of DGBs, one could design gas-releasing materials that release multiple gases in either synergistic or cascading mode (Figure 8, right panel), which provides an enhanced or diminished effect for biomedical applications, such as gas therapeutics.…”
Section: Discussionmentioning
confidence: 99%
“…However, gasotransmitters do not act individually in the body; they are usually implemented in physiological processes on either a synergistic or antagonistic role through subtle interactions among them. 48 By availing of the reversibility of DGBs, one could design gas-releasing materials that release multiple gases in either synergistic or cascading mode (Figure 8, right panel), which provides an enhanced or diminished effect for biomedical applications, such as gas therapeutics.…”
Section: Discussionmentioning
confidence: 99%
“…Hydrogen sulfide (H2S) is an endogenously produced gas with known antioxidant and neuroprotective properties. H2S has a complex interaction with NO, which can upregulate eNOS expression, increase NO bioavailability by reducing oxidative stress, and enhance downstream NO signaling by inhibiting PDE5A activity [80]. Like NO, enhanced H2S production has been proposed as a universal response to hypoxic stress.…”
Section: Potential Mechanisms Regulating Renin Under Hypoxiamentioning
confidence: 99%
“…NO binding to sGC induces an increase in cGMP formation, thereby amplifying the initial NO signal through a series of processes that further activate cGMP-dependent protein kinases, ion channels, and phosphodiesterases [ 15 , 16 ]. Therefore, the dysregulation of the NO-sGC-cGMP signaling pathway is associated with a variety of diseases, such as cancer and hypertension as well as cardiovascular and neurodegenerative diseases [ 17 , 18 , 19 , 20 ]. On the other hand, NO scavenging by various heme proteins, including hemoglobin (Hb) and myoglobin (Mb), can have contrasting effects by inducing vasoconstriction [ 21 ].…”
Section: Introductionmentioning
confidence: 99%